48 completed. 48 Phase 1, 21 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 48 | Completed 48 |
| Phase 2 | 21 | Completed 21 |
Follow Myocardial Infarction: new trials by email Literature Review of Myocardial Infarction trials Research Report on Myocardial Infarction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Research Study to Evaluate the Safety and Preliminary Efficacy of SGC001 in Patients With Myocardial Infarction SGC001, Placebo - Anterior Myocardial Infarction | Phase 1 | Completed | Beijing Sungen Biomedical Technology Co., Ltd | 38 | 2025-01-20 | 2026-01-12 |
| A Research Study to Evaluate the Safety and Tolerability of SGC001 in Healthy Subjects SGC001, Placebo - Anterior Myocardial Infarction | Phase 1 | Completed | Beijing Sungen Biomedical Technology Co., Ltd | 49 | 2024-08-20 | 2025-11-25 |
| Study to Compare the Pharmacodynamics and Pharmacokinetics of Acetylsalicylic Acid Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Healthy Adults. ASA, non-enteric-coated chewable aspirin - Healthy Volunteers | Phase 1 | Completed | Vectura, Inc. | 86 | 2022-10-14 | 2024-03-22 |
| A Study of NP-011 in Healthy Volunteers NP-011 (Single Ascending Dose Phase), NP-011 (Multiple Ascending Dose Phase), NP-011 (Placebo) - Myocardial Infarction | Phase 1 | Completed | Nexel Co., Ltd. | 64 | 2022-06-10 | 2023-08-03 |
| MiSaver® Stem Cell Treatment for Heart Attack (Acute Myocardial Infarction) MiSaver® - Myocardial Infarction | Phase 1 / Phase 2 | Completed | Honya Medical Inc | 11 | 2021-01-26 | 2024-03-29 |
| SP16 Inflammatory Response Inhibition Trial SP16 - Myocardial Infarction, Inflammation | Phase 1 / Phase 2 | Completed | Serpin Pharma, LLC | 10 | 2020-02-24 | 2023-01-30 |
| Neuroinflammation After Myocardial Infarction - Imaging Substudy [18F]DPA-714-PET/MRI - Myocardial Infarction | Phase 1 | Completed | University of Alabama at Birmingham | 6 | 2019-10-17 | 2026-08-26 |
| The MOCA I Study - Microvascular Obstruction with CoFI™ System Assessment CorFlow Controlled Flow Infusion System - CoFI™ - STEMI - ST Elevation Myocardial Infarction, Microvascular Obstruction | Phase 1 | Completed | CorFlow Therapeutics AG | 73 | 2019-06-04 | 2025-03-19 |
| Pericardial Matrix With Mesenchymal Stem Cells for the Treatment of Patients With Infarcted Myocardial Tissue PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton´s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix., Surgery by sternotomy - Myocardial Infarction | Phase 1 | Completed | Fundació Institut Germans Trias i Pujol | 12 | 2019-05-13 | 2022-12-02 |
| Rituximab in Patients With Acute ST-elevation Myocardial Infarction Study RiTUXimab Injection - Ischemic Heart Disease, Myocardial Infarction | Phase 1 / Phase 2 | Completed | Papworth Hospital NHS Foundation Trust | 24 | 2017-06-01 | 2021-09-14 |
| Safety and Feasibility of Intracoronary Hypothermia in Acute Myocardial Infarction intracoronary infusion with saline on 22 and 4°C - Myocardial Infarction | Phase 1 / Phase 2 | Completed | Catharina Ziekenhuis Eindhoven | 10 | 2016-06-01 | 2016-11-22 |
| A Study of VentriGel in Post-MI Patients VentriGel - Myocardial Infarction, Heart Failure | Phase 1 | Completed | Ventrix, Inc. | 15 | 2015-09-01 | 2019-10-25 |
| Clinical Trial of Manganese-Enhanced MRI (MEMRI) to Assess Peri-Infarct Injury Manganese-enhanced MRI contrast reagent, Gadolinium-enhanced MRI contrast reagent - ISCHEMIC CARDIOMYOPATHY | Phase 1 / Phase 2 | Completed | Stanford University | 33 | 2015-04-01 | 2020-02-17 |
| Controlled Level EVERolimus in Acute Coronary Syndromes Everolimus, Placebo - Acute Coronary Syndromes | Phase 1 / Phase 2 | Completed | University of Zurich | 150 | 2015-01-08 | 2021-12-03 |
| Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers Salmonella typhi vaccine (Typhim Vi®), Oxygen (Oxymask®), Atorvastatin - Myocardial Infarction, Inflammation | Phase 1 | Completed | Karolinska Institutet | 36 | 2014-10-01 | 2017-12-11 |
| CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function CD-NP - ST Elevation (STEMI) Myocardial Infarction of Anterior Wall | Phase 1 | Completed | Mayo Clinic | 30 | 2013-10-01 | 2021-03-10 |
| Efficacy of EVP 1001-1 (SeeMore) in the Assessment of Myocardial Viability in Patients With Cardiovascular Disease 'SEEMORE' - MANGANESE-ENHANCED MRI CONTRAST REAGENT - ISCHEMIC CARDIOMYOPATHY | Phase 1 / Phase 2 | Completed | Stanford University | 6 | 2013-05-01 | 2017-01-02 |
| Pericardic Adipose Pedicle Transposition Over the Myocardial Infarct (adiFLAP Trial) Pericardial adipose pedicle (adiFLAP) transposition., Control - Myocardial Infarction | Phase 1 / Phase 2 | Completed | Germans Trias i Pujol Hospital | 10 | 2012-01-01 | 2015-07-24 |
| Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy Pharmacogenomics testing for clopidogrel responsiveness - Stroke, Transient Ischemic Attack | Phase 1 | Completed | University of North Carolina, Chapel Hill | 48 | 2011-12-01 | 2012-06-08 |
| Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack mecasermin, 0.9% sodium chloride injection - Heart Failure, Myocardial Infarction | Phase 1 / Phase 2 | Completed | University College Cork | 47 | 2011-10-01 | 2017-03-30 |
Showing 20 of 48. Sign in to see all of them.
Coronary Artery Disease (8) · ST Elevation Myocardial Infarction (7) · Heart Failure (6) · Inflammation (5) · Acute Coronary Syndrome (4) · Cardiovascular Diseases (4) · Stroke (3) · Anterior Wall Myocardial Infarction (2) · Coronary Disease (2) · Myocardial Ischemia (2) · Respiratory Aspiration (2) · Thrombosis (2) · Ventricular Dysfunction (2) · Angina Pectoris (1)
Ischemia (48) · Necrosis (48) · Pathologic Processes (48) · Pathological Conditions, Signs and Symptoms (48) · Vascular Diseases (48) · Heart Diseases (47) · Infarction (47) · Myocardial Ischemia (46) · Cardiovascular Diseases (44) · Arterial Occlusive Diseases (9) · Arteriosclerosis (9) · Coronary Disease (6) · Brain Diseases (3) · Central Nervous System Diseases (3)
3-(2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl)phenol (1) · Aspirin (1) · Atorvastatin (1) · Celecoxib (1) · Docosahexaenoic Acids (1) · EVP 1001-1 (1) · Everolimus (1) · Fish Oils (1) · Gadolinium DTPA (1) · Iloprost (1) · Indomethacin (1) · Injections (1) · Insulin-Like Growth Factor I (1) · Ischemic Preconditioning (1) · KAI 9803 (1)
Beijing Sungen Biomedical Technology Co., Ltd (2) · Cedars-Sinai Medical Center (2) · Emory University (2) · Stanford University (2) · Abbott Medical Devices (1) · AdvanceCor GmbH (1) · BioCardia, Inc. (1) · Catharina Ziekenhuis Eindhoven (1) · Center for Veterans Research and Education (1) · CorFlow Therapeutics AG (1) · Cytori Therapeutics (1) · Fundació Institut Germans Trias i Pujol (1) · Gaia Hospital (1) · Germans Trias i Pujol Hospital (1) · Hannover Medical School (1)
United States (24) · Netherlands (5) · Germany (4) · Spain (3) · Canada (2) · China (2) · Denmark (2) · Switzerland (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Finland (1) · France (1) · India (1) · Ireland (1)
Adelino Leite-Moreira, PhD (1) · Andreas Wielgosz, MD, FRCP(C) (1) · Andrew Pipe, MD (1) · Antonio Abbate, MD, PhD (1) · Chris Blanchard, PhD (1) · Douglas C Morris, MD (1) · Eduardo Marban, MD, PhD (1) · Eric Duckers, MD, PhD (1) · Frank Ruschitzka, Professor (1) · Gabriel P. Lasala, M.D. (1) · George Wells, PhD (1) · Helmut Drexler, MD (1) · Horng Chen, MD (1)
PMID 15246726, PMID 19679246, PMID 19958962, PMID 21330601, PMID 21422390, PMID 21454794, PMID 21492763, PMID 21502572, PMID 21717276, PMID 22052917, PMID 22088800, PMID 22336189, PMID 22951358, PMID 22965994, PMID 22971949, PMID 23633132, PMID 23778184, PMID 23979567, PMID 24036024, PMID 24815497, PMID 25484310, PMID 25872588, PMID 27322478, PMID 30602360, PMID 33783498, PMID 35092722, PMID 35750637, PMID 35881895, PMID 36049557, PMID 39921502, PMID 42797369
2014 (1), 2018 (1), R01HL103927 (1), U54HL081028 (1)